Behavioral Health Market Research Reports & Industry Analysis
Extraordinary advances have been made in the treatment of mental illness. An understanding of what causes some mental health disorders has led to greater sophistication in tailoring treatment to the underlying basis of each disorder. As a result, many mental health disorders can now be treated nearly as successfully as physical disorders. Most treatment methods for mental health disorders can be categorized as either somatic or psychotherapeutic. Somatic treatments include drug therapy and electroconvulsive therapy. Psychotherapeutic treatments include individual, group, or family and marital psychotherapy; behavior therapy techniques (such as relaxation training or exposure therapy); and hypnotherapy. Most studies suggest that for major mental health disorders, a treatment approach involving both drugs and psychotherapy is more effective than either treatment method used alone.
The psychotherapeutic drug industry continues to struggle through a morass of issues that are directly or indirectly affecting competition. Some hurdles recently faced by competitors in this market include advertising restrictions, label changes, and some general negative views about mental illness treatments. However, there have been considerable strides in many areas of the market including advanced delivery techniques, increased education and awareness efforts, and improved effectiveness.
Behavioral Health Industry Research & Market Reports
-
Gummy Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Digestive Health, Heart Health, Immune Health, Stress Management, Brain Health, Skin Health, Healthy Ageing, Sports Nutrition, Weight Loss, Multivitamins, Single Vitamins, Probiotics, Men’s Health, Women’s Health, and Others) and End User (Adults and Kids)
... Probiotics, Men’s Health, Women’s Health, and Others) and End User (Adults and Kids) The gummy supplements market is projected to reach US$ 16,510.39 million by 2028 from US$ 9,467.04 million in 2021. It is expected ... Read More
-
Vagus Nerve Stimulators Market by Product Type (Implantable Devices, and External Devices), by Application (Epilepsy, Depression, Cluster Headache & Migraine, and Others), by Distribution Channel (Hospital, Specialty Pharmacy, and Others), by Distribution
... Pharmacy, and Online Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Vagus nerve stimulation (VNS) refers to a ... Read More
-
Autism Spectrum Disorder Therapeutics Market, by Drug Type (Aripiprazole, Risperidone, Melatonin, CM-AT, Bumetanide, and Balovaptan), by Age Group (Child and Adult), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies),
... America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Autism, scientifically referred as Autism Spectrum Disorder Therapeutics (ASD) is a complex neurological disorder that ... Read More
-
U.S. Speech Therapy Market, by Age Group (Children and Adults), by Indication (Speech Disorders, Language Disorders, Apraxia, Autism Spectrum Disorder (ASD), and Others), and by End User (Hospitals, Clinics, Rehabilitation Centers, and Others) - Size, Sha
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 The demand of speech therapy has been dynamically increasing in the U.S., owing to increasing prevalence of language and speech disorders. The National Institute on Deafness and ... Read More
-
Neurotech Devices Market Size By Product Type (Neurostimulation {Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation (TENS)}, Neuroprostheses, Neurosensing, Neurorehabilitation Devices), By Conditions (Pain Management, Cognitive Disorders, Epilepsy, Urinary and Fecal Incontinence, Hearing Conditions, Parkinson's Disease, Depression, Sleep Disorders, Essential Tremor), By End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030
... Management, Cognitive Disorders, Epilepsy, Urinary and Fecal Incontinence, Hearing Conditions, Parkinson's Disease, Depression, Sleep Disorders, Essential Tremor), By End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities), Industry Analysis Report, Regional Outlook, COVID-19 Impact Analysis, Growth Potential, ... Read More
-
Global Mental Health Apps Market Size study, by Platform (iOS, Android and Others), by Application (Depression and Anxiety Management, Meditation Management, Stress Management and Others) and Regional Forecasts 2022-2028
... valued at approximately USD 3.61 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.5% over the forecast period 2022-2028. Mental Health Apps allow doctors to provide care ... Read More
-
Bipolar Disorder Treatment Market, By Drug Class (Antipsychotics, Antidepressants, Mood Stabilizers, and Anti-anxiety Drugs and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America,
... Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Bipolar disorder is a lifelong disease, which can be managed with proper medication. The medications used to manage bipolar disorder ... Read More
-
Global Bruxism Management Market Size study, By Type (Diurnal Bruxism, Nocturnal Bruxism), By Treatment Type (Drugs, Antianxiety Agents, Tranquilizers, Sedatives, Muscle Relaxants, Dental Approaches, Occlusal Splint, Mouth Guard), By Cause (Obstructive Sleep Apnea, Sleep Paralysis, Malocclusion, Gastroesophageal Reflux Disease (GERD), Depression, Anxiety, Others) By Distribution Channel (Institutional Sales, Hospital, Dental Clinic, Retail Sales, Drug Store, Retail Store, Supermarket, Mail Order Pharmacies), and Regional Forecasts 2022-2028
... Malocclusion, Gastroesophageal Reflux Disease (GERD), Depression, Anxiety, Others) By Distribution Channel (Institutional Sales, Hospital, Dental Clinic, Retail Sales, Drug Store, Retail Store, Supermarket, Mail Order Pharmacies), and Regional Forecasts 2022-2028 Global Bruxism Management Market is ... Read More
-
Melatonin Market, By Application (Dietary Supplements, Medicine, Food & Beverages, Others), and By Region (North America, Europe, Asia Pacific, Latin America, MEA) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... hormone that helps in regulating the sleep-wake cycle and is produced naturally in the body. It is synthetically produced in a laboratory for treating short-term treatment of insomnia. It has antioxidant properties which expand its ... Read More
-
The 2023-2028 World Outlook for Antidepressants
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2023-2028 World Outlook for Anxiety Disorders and Depression Treatments
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Acute Agitation and Aggression Treatments
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Behavioral Rehabilitation
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Mood Stabilizers for Bipolar Disorders
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Substance Abuse Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Bipolar Disorders
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Bipolar Disorder Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Benzodiazepine Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Antidepressant and Anti-Anxiety Drugs
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Depression Screenings
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Antidepressant Pharmaceuticals
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Autism Spectrum Disorder Therapeutics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Depression Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Anxiety Disorder Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Attention Deficit Hyperactivity Disorders
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
Research Assistance
